CoChat
Sign Up
Cited by 122Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsGut microbiota and health

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease

Open access
Mezö, Charlotte, Dokalis, Nikolaos, Mossad, Omar, Staszewski, Ori, Neuber, Jana, Yilmaz, Bahtiyar, Schnepf, Daniel, de Agüero, Mercedes Gomez, Ganal-Vonarburg, Stephanie C., Macpherson, Andrew J., Meyer-Luehmann, Melanie, Staeheli, Peter, Blank, Thomas, Prinz, Marco, Erny, Daniel·2020·Acta Neuropathologica Communications
DOI 10.1186/s40478-020-00988-5PMC PMC7389451
Open this paper in CoChat — free accountOpen PDF

Abstract

It was recently revealed that gut microbiota promote amyloid-beta (Aβ) burden in mouse models of Alzheimer’s disease (AD). However, the underlying mechanisms when using either germ-free (GF) housing conditions or treatments with antibiotics (ABX) remained unknown. In this study, we show that GF and ABX-treated 5x familial AD (5xFAD) mice developed attenuated hippocampal Aβ pathology and associated neuronal loss, and thereby delayed disease-related memory deficits. While Aβ production remained unaffected in both GF and ABX-treated 5xFAD mice, we noticed in GF 5xFAD mice enhanced microglial Aβ uptake at early stages of the disease compared to ABX-treated 5xFAD mice. Furthermore, RNA-sequencing of hippocampal microglia from SPF, GF and ABX-treated 5xFAD mice revealed distinct microbiota-dependent gene expression profiles associated with phagocytosis and altered microglial activation states. Taken together, we observed that constitutive or induced microbiota modulation in 5xFAD mice differentially controls microglial Aβ clearance mechanisms preventing neurodegeneration and cognitive deficits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-020-00988-5

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Absence of host microbiota reduces hippocampal Aβ depositions of 5xFAD mice. (a) Representative fluorescence images of thiazine red+ (TR; red) compact Aβ plaques in the hippocampus of 4 months old SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnification of subiculum (dashed line) are shown. Scale bars represent 300 μm (overview) and 50 μm (insert). (b) Quantification of the number of TR+ Aβ-plaques per mm2, (c) percentage of TR+ area and (d) average TR+ plaque size (μm2) in coronal hippocampal sections. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). Data are representative of four independent experiments. Enzyme-linked immunosorbent assay (ELISA) for (e) insoluble Aβ42, (f) insoluble Aβ40, (g) soluble Aβ42 and (h) soluble Aβ40 fractions of hippocampal brain extracts from 4 months old SPF, GF and ABX-treated 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of two independent experiments. (i) Representative immunoblots of hippocampal brain homogenates from 4 months old SPF, GF and ABX-treated 5xFAD mice against human full-length amyloid precursor protein (APP-FL), C-terminal fragment (CTF) α, CTF-β, β-site of APP cleaving enzyme (BACE) 1, A Disintegrin And Metalloproteinase (ADAM10), γ-secretase complex (Nicastrin, presenilin enhancer (PEN) 2, Presenilin (PS) 1, PS2) and Aβ (6E10). β-Actin was used as loading control. Each lane represents one mouse. Quantification of (j) APP-FL, (k), CTF-β, (l) CTF-α, (m) BACE1, (n) ADAM10, (o) PS1, (p) PS2, (q) PEN2, (r) Nicastrin, and (s) Aβ protein levels normalized to β-Actin are shown. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P < 0.05). Data are representative of two independent experiments. (t) Representative fluorescence images of TR+ compact Aβ plaques in the hippocampus of 10 months old 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnification of subiculum (dashed line) are shown. Scale bars represent 300 μm (overview) and 50 μm (insert). (u) Quantification of the number of TR+ Aβ-plaques per area (mm2), (v) percentage of TR+ area and (w) average of TR+ plaque size (μm2). Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of four independent experiments
Fig. 1 Absence of host microbiota reduces hippocampal Aβ depositions of 5xFAD mice. (a) Representative fluorescence images of thiazine red+ (TR; red) compact Aβ plaques in the hippocampus of 4 months old SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnification of subiculum (dashed line) are shown. Scale bars represent 300 μm (overview) and 50 μm (insert). (b) Quantification of the number of TR+ Aβ-plaques per mm2, (c) percentage of TR+ area and (d) average TR+ plaque size (μm2) in coronal hippocampal sections. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). Data are representative of four independent experiments. Enzyme-linked immunosorbent assay (ELISA) for (e) insoluble Aβ42, (f) insoluble Aβ40, (g) soluble Aβ42 and (h) soluble Aβ40 fractions of hippocampal brain extracts from 4 months old SPF, GF and ABX-treated 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of two independent experiments. (i) Representative immunoblots of hippocampal brain homogenates from 4 months old SPF, GF and ABX-treated 5xFAD mice against human full-length amyloid precursor protein (APP-FL), C-terminal fragment (CTF) α, CTF-β, β-site of APP cleaving enzyme (BACE) 1, A Disintegrin And Metalloproteinase (ADAM10), γ-secretase complex (Nicastrin, presenilin enhancer (PEN) 2, Presenilin (PS) 1, PS2) and Aβ (6E10). β-Actin was used as loading control. Each lane represents one mouse. Quantification of (j) APP-FL, (k), CTF-β, (l) CTF-α, (m) BACE1, (n) ADAM10, (o) PS1, (p) PS2, (q) PEN2, (r) Nicastrin, and (s) Aβ protein levels normalized to β-Actin are shown. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P < 0.05). Data are representative of two independent experiments. (t) Representative fluorescence images of TR+ compact Aβ plaques in the hippocampus of 10 months old 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnification of subiculum (dashed line) are shown. Scale bars represent 300 μm (overview) and 50 μm (insert). (u) Quantification of the number of TR+ Aβ-plaques per area (mm2), (v) percentage of TR+ area and (w) average of TR+ plaque size (μm2). Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of four independent experimentsCC BY · PubMed Central
Fig. 2 Restored memory deficits in 5xFAD mice lacking microbes. (a-c) T-maze test performance of 10 months old SPF and GF 5xFAD mice, as well as aged-matched WT controls or (d-f) of 10 months old SPF and ABX 5xFAD mice, as well as WT controls. (g-i) Novel object recognition test (NOR) of 10 months old SPF and GF 5xFAD mice, as well as age-matched WT controls or (j-l) of 10 months old SPF and ABX 5xFAD mice, as well as respective WT controls. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). Data are representative of three independent experiments. (m) Representative immunofluorescence images of NeuN+ neurons (green) and TR+ (red) compact Aβ plaques in the subiculum (Sub), cornu ammonis (CA) 1, CA3 and dentate gyrus (DG) of the hippocampus of 10 months old SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnifications of subiculum, CA1, CA3 and DG (dashed lines) are shown. Scale bars represent 200 μm (overview) and 50 μm (inserts). Quantification of the number of NeuN+ neurons per mm2 in the subiculum (n), CA1 (o), CA3 (p) and DG (q) of sagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD and age-matched WT mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of two independent experiments
Fig. 2 Restored memory deficits in 5xFAD mice lacking microbes. (a-c) T-maze test performance of 10 months old SPF and GF 5xFAD mice, as well as aged-matched WT controls or (d-f) of 10 months old SPF and ABX 5xFAD mice, as well as WT controls. (g-i) Novel object recognition test (NOR) of 10 months old SPF and GF 5xFAD mice, as well as age-matched WT controls or (j-l) of 10 months old SPF and ABX 5xFAD mice, as well as respective WT controls. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). Data are representative of three independent experiments. (m) Representative immunofluorescence images of NeuN+ neurons (green) and TR+ (red) compact Aβ plaques in the subiculum (Sub), cornu ammonis (CA) 1, CA3 and dentate gyrus (DG) of the hippocampus of 10 months old SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Overview of hippocampus and magnifications of subiculum, CA1, CA3 and DG (dashed lines) are shown. Scale bars represent 200 μm (overview) and 50 μm (inserts). Quantification of the number of NeuN+ neurons per mm2 in the subiculum (n), CA1 (o), CA3 (p) and DG (q) of sagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD and age-matched WT mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of two independent experimentsCC BY · PubMed Central
Fig. 3 Increased microglial phagocytosis in the hippocampus of 4 months old GF 5xFAD mice. (a) Representative immunofluorescence images of TR+ (red) Aβ depositions and Iba1+ (green) microglia on coronal hippocampal sections of SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. Quantification of (b) Iba1+ parenchymal microglia in hippocampus of 5xFAD and age-matched WT mice. Quantification of (c) TR+ plaque-associated microglia in 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test or by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of four independent experiments. (d) Gating of CD11b+methoxy-XO-4+ microglia from SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Representative dot plots are shown. (e) Representative cytometric graph of methoxy-X-O4+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective WT controls (dashed lines). (f) Quantification of percentages of methoxy-X-O4+ labelled microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (***P < 0.001). Data are representative of four independent experiments
Fig. 3 Increased microglial phagocytosis in the hippocampus of 4 months old GF 5xFAD mice. (a) Representative immunofluorescence images of TR+ (red) Aβ depositions and Iba1+ (green) microglia on coronal hippocampal sections of SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. Quantification of (b) Iba1+ parenchymal microglia in hippocampus of 5xFAD and age-matched WT mice. Quantification of (c) TR+ plaque-associated microglia in 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test or by one-way ANOVA followed by Tukey’s post-hoc comparison test (**P < 0.01, ***P < 0.001). Data are representative of four independent experiments. (d) Gating of CD11b+methoxy-XO-4+ microglia from SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Representative dot plots are shown. (e) Representative cytometric graph of methoxy-X-O4+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective WT controls (dashed lines). (f) Quantification of percentages of methoxy-X-O4+ labelled microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test (***P < 0.001). Data are representative of four independent experimentsCC BY · PubMed Central
Fig. 4 Altered microglial gene expression profiles in 5xFAD mice housed under GF conditions. (a) Venn diagram depicting the different regulated and overlapping genes between FACS-isolated hippocampal microglia of SPF, GF and ABX-treated 5xFAD animals compared to respective non-transgenic littermates of the same conditions (SPF/GF/ABX). (b) RNA-Seq analysis presenting mRNA expression profile of genes, whose expression was either induced or reduced with an adjusted P value < 0.0001 in hippocampal microglia of SPF, GF and ABX-treated transgenic 5xFAD animals and respective age-matched WT littermates. Representative genes are noted on the right. One column represents microglia from one individual mouse. Three to five mice were investigated per condition. Color code presents z-score (red: upregulated, blue: downregulated). Ingenuity pathway analysis (Qiagen) on differentially expressed genes in hippocampal microglia of SPF (c), GF (d) and ABX-treated (e) 5xFAD animals compared to respective WT littermates of the same housing/treatment conditions (SPF/GF/ABX) based on an RNA-sequencing analysis. Diagram depicts –log(p) value and predicted activation z-scores (red: increased activity, blue: reduced activity; grey: no predicted z-score available). (f) Heatmap of differently expressed genes attributed to the pathway ‘phagosome maturation’ of hippocampal microglia from SPF, GF and ABX-treated transgenic 5xFAD animals and respective age-matched WT littermates. Representative genes are noted on the bottom. One row represents microglia from one individual mouse. Three to five mice were investigated per condition. Color code presents z-score (red: upregulated, blue: downregulated)
Fig. 4 Altered microglial gene expression profiles in 5xFAD mice housed under GF conditions. (a) Venn diagram depicting the different regulated and overlapping genes between FACS-isolated hippocampal microglia of SPF, GF and ABX-treated 5xFAD animals compared to respective non-transgenic littermates of the same conditions (SPF/GF/ABX). (b) RNA-Seq analysis presenting mRNA expression profile of genes, whose expression was either induced or reduced with an adjusted P value < 0.0001 in hippocampal microglia of SPF, GF and ABX-treated transgenic 5xFAD animals and respective age-matched WT littermates. Representative genes are noted on the right. One column represents microglia from one individual mouse. Three to five mice were investigated per condition. Color code presents z-score (red: upregulated, blue: downregulated). Ingenuity pathway analysis (Qiagen) on differentially expressed genes in hippocampal microglia of SPF (c), GF (d) and ABX-treated (e) 5xFAD animals compared to respective WT littermates of the same housing/treatment conditions (SPF/GF/ABX) based on an RNA-sequencing analysis. Diagram depicts –log(p) value and predicted activation z-scores (red: increased activity, blue: reduced activity; grey: no predicted z-score available). (f) Heatmap of differently expressed genes attributed to the pathway ‘phagosome maturation’ of hippocampal microglia from SPF, GF and ABX-treated transgenic 5xFAD animals and respective age-matched WT littermates. Representative genes are noted on the bottom. One row represents microglia from one individual mouse. Three to five mice were investigated per condition. Color code presents z-score (red: upregulated, blue: downregulated)CC BY · PubMed Central
Fig. 5 Altered expression of activation markers in hippocampal microglia from GF 5xFAD mice. Expression levels (counts per million) of (a) ApoE, (b) P2ry12, (c) Clec7a and (d) Itgax in hippocampal microglia from SPF, GF and ABX-treated 5xFAD and age-matched WT mice, based on RNA-seq data depicted in Fig. 4. Each symbol represents one mouse. Data are presented as mean ± s.e.m. (e) Representative immunofluorescence images of Iba1+ (red), P2ry12+ (green) microglia and TR+ (white) Aβ on parasagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate P2ry12dim/Iba1+ microglia and non-filled arrowheads show P2ry12bright/Iba1+ microglia. Quantification of the percentage of (f) total parenchymal P2ry12dim/Iba1+ microglia (g) TR+ plaque-associated P2ry12dim/Iba1+ microglia and (h) non-plaque-associated P2ry12dim/Iba1+ microglia in hippocampi of SPF, GF and ABX-treated 5xFAD mice. (i) Representative immunofluorescence images of Iba1+ (red) ApoE+ (green) microglia and TR+ (white) Aβ on parasagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate ApoE+/Iba1+ microglia and non-filled arrowheads show ApoE−/Iba1+ microglia. Quantification of the percentage of (j) total parenchymal ApoE+/Iba1+ microglia (k) TR+ plaque-associated ApoE+/Iba1+ microglia and (l) non-plaque-associated ApoE+/Iba1+ microglia in hippocampus from SPF, GF and ABX-treated 5xFAD mice. (m) Representative immunofluorescence images of Iba1+ (red) Clec7a+ microglia (green) and TR+ (white) on coronal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate Clec7a+/Iba1+ microglia and non-filled arrowheads show Clec7a−/Iba1+ microglia. Quantification of the percentage of (n) total parenchymal Clec7a+/Iba1+ microglia (o) TR+ plaque-associated Clec7a+/Iba1+ microglia and (p) non-plaque-associated Clec7a+/Iba1+ microglia in hippocampus of SPF, GF and ABX-treated 5xFAD mice. Each symbol represents one mouse. At least three slides were examined per individual mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P<0.001). Data are representative of two independent experiments. (q) Representative cytometric graph of CD11c+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective age-matched WT mice (dashed lines), compared to the isotype control (green line). In addition, quantifications of (r) percentages and (s) geometric mean fluorescence intensities (gMFI) of CD11c+ microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test or by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P<0.05, ***P < 0.001). Data are representative of three independent experiments
Fig. 5 Altered expression of activation markers in hippocampal microglia from GF 5xFAD mice. Expression levels (counts per million) of (a) ApoE, (b) P2ry12, (c) Clec7a and (d) Itgax in hippocampal microglia from SPF, GF and ABX-treated 5xFAD and age-matched WT mice, based on RNA-seq data depicted in Fig. 4. Each symbol represents one mouse. Data are presented as mean ± s.e.m. (e) Representative immunofluorescence images of Iba1+ (red), P2ry12+ (green) microglia and TR+ (white) Aβ on parasagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate P2ry12dim/Iba1+ microglia and non-filled arrowheads show P2ry12bright/Iba1+ microglia. Quantification of the percentage of (f) total parenchymal P2ry12dim/Iba1+ microglia (g) TR+ plaque-associated P2ry12dim/Iba1+ microglia and (h) non-plaque-associated P2ry12dim/Iba1+ microglia in hippocampi of SPF, GF and ABX-treated 5xFAD mice. (i) Representative immunofluorescence images of Iba1+ (red) ApoE+ (green) microglia and TR+ (white) Aβ on parasagittal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate ApoE+/Iba1+ microglia and non-filled arrowheads show ApoE−/Iba1+ microglia. Quantification of the percentage of (j) total parenchymal ApoE+/Iba1+ microglia (k) TR+ plaque-associated ApoE+/Iba1+ microglia and (l) non-plaque-associated ApoE+/Iba1+ microglia in hippocampus from SPF, GF and ABX-treated 5xFAD mice. (m) Representative immunofluorescence images of Iba1+ (red) Clec7a+ microglia (green) and TR+ (white) on coronal hippocampal sections from SPF, GF and ABX-treated 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. White arrowheads indicate Clec7a+/Iba1+ microglia and non-filled arrowheads show Clec7a−/Iba1+ microglia. Quantification of the percentage of (n) total parenchymal Clec7a+/Iba1+ microglia (o) TR+ plaque-associated Clec7a+/Iba1+ microglia and (p) non-plaque-associated Clec7a+/Iba1+ microglia in hippocampus of SPF, GF and ABX-treated 5xFAD mice. Each symbol represents one mouse. At least three slides were examined per individual mouse. Data are presented as mean ± s.e.m. Significant differences were determined by one-way ANOVA (*P < 0.05, **P < 0.01, ***P<0.001). Data are representative of two independent experiments. (q) Representative cytometric graph of CD11c+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective age-matched WT mice (dashed lines), compared to the isotype control (green line). In addition, quantifications of (r) percentages and (s) geometric mean fluorescence intensities (gMFI) of CD11c+ microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni’s post-hoc comparison test or by one-way ANOVA followed by Tukey’s post-hoc comparison test (*P<0.05, ***P < 0.001). Data are representative of three independent experimentsCC BY · PubMed Central
Fig. 6 Equalized microglial Aβ phagocytosis in the hippocampus of aged 5xFAD mice. (a) Representative immunofluorescence images of TR (red) and Iba1 (green) on coronal hippocampal sections from 10 months old 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. Quantification of (b) Iba1+ parenchymal in hippocampus of 5xFAD and age-matched WT mice. Quantification of (c) TR+ plaque-associated microglia in 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni post-hoc comparison test (**P < 0.01, ***P < 0.001). (d) Gating of CD11b+methoxy-XO4+microglia from SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Representative flow cytometric dot plots are shown. (e) Representative cytometric graph of methoxy-X-O4+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective WT controls (dashed lines). (f) Quantification of percentages of methoxy-X-O4+ labelled microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m.: No significant differences were detected by two-way ANOVA followed by Bonferroni post-hoc comparison test. Data are representative of three independent experiments
Fig. 6 Equalized microglial Aβ phagocytosis in the hippocampus of aged 5xFAD mice. (a) Representative immunofluorescence images of TR (red) and Iba1 (green) on coronal hippocampal sections from 10 months old 5xFAD mice. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. Quantification of (b) Iba1+ parenchymal in hippocampus of 5xFAD and age-matched WT mice. Quantification of (c) TR+ plaque-associated microglia in 5xFAD mice. Each symbol represents one mouse. Data are presented as mean ± s.e.m. Significant differences were determined by two-way ANOVA followed by Bonferroni post-hoc comparison test (**P < 0.01, ***P < 0.001). (d) Gating of CD11b+methoxy-XO4+microglia from SPF, GF and ABX-treated 5xFAD mice and age-matched WT controls. Representative flow cytometric dot plots are shown. (e) Representative cytometric graph of methoxy-X-O4+ labelled microglia from SPF (black line), GF (red line) and ABX-treated (blue line) 5xFAD mice and respective WT controls (dashed lines). (f) Quantification of percentages of methoxy-X-O4+ labelled microglia cells are depicted. Each symbol represents one mouse. Data are presented as mean ± s.e.m.: No significant differences were detected by two-way ANOVA followed by Bonferroni post-hoc comparison test. Data are representative of three independent experimentsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 1

  1. Raivo K (2019) Pheatmap: pretty Heatmaps. R package version 1.0.12., City

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Mezö, C., Dokalis, N., Mossad, O., Staszewski, O., Neuber, J., Yilmaz, B., Schnepf, D., de Agüero, M. G., Ganal-Vonarburg, S. C., Macpherson, A. J., Meyer-Luehmann, M., Staeheli, P., Blank, T., Prinz, M., & Erny, D.
Affiliations
  • University of Freiburg (DE)
  • University of Bern (CH)
Corresponding author
Erny, Daniel
ORCID
Venue
Acta Neuropathologica Communications
Publisher
Springer Science and Business Media LLC
Published
2020-07-29
Volume
8
Issue
1
Pages
119-119
ISSN
2051-5960 (ISSN-L)
DOI
10.1186/s40478-020-00988-5
PMC
PMC7389451
OpenAlex
W3046110242
Cited by
120
References
65
Citations by year
2026: 8 · 2025: 20 · 2024: 24 · 2023: 22 · 2022: 21 · 2021: 23 · 2020: 2
FWCI
10.23
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Deutsche Forschungsgemeinschaft (SFB/TRR167, SFB 992, SFB1160, Reinhart Koselleck Grant)
  • Berta-Ottenstein-Programme
  • Dr. Kübler-Chicken-Stiftung (1027095701)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
gut microbiota, Alzheimer's disease, microglia, amyloid-beta clearance, antibiotic therapy, 5xFAD mice, hippocampus, memory impairment, neurodegeneration, phagocytosis, microglial activation, gene expression profiling
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Animals, Anti-Bacterial Agents, Disease Models, Animal, Germ-Free Life, Hippocampus, Humans, Male, Amyloid beta-Protein Precursor, Microglia, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review